Cited by 98Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and ResearchHealthcare Systems and Public Health

Cause-specific mortality in diabetes: recent changes in trend mortality

Khalil, Charbel Abi, Roussel, Ronan, Mohammedi, Kamel, Danchin, Nicolas, Marre, Michel·2012·European Journal of Preventive Cardiology

Abstract

Diabetes is one of the most chronic diseases in Western populations. Mortality rates in diabetic patients are higher than in the general population and their prognosis following any cardiovascular event is generally worse. Type 1 diabetic patients’ acute complications-related mortality decreases with time and the interval free from the diagnosis of diabetes until the development of chronic complications is larger although global mortality is still higher than that of sex- and age-matched healthy individuals. As a consequence of better primary and secondary preventions, recent data in the general population show that there is a trend towards decreased cardiovascular events and increased life expectancy. The same thing applies for type 2 diabetic patients. However, increased survival in the general population associated to epidemic bursts of obesity and sedentarily all over the globe, leads to a higher incidence of type 2 diabetes worldwide. This counteracts the diminution of diabetes-related mortality that would move forward on an ascending slope in the next decades.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1177/1741826711409324

Cites

52 of 52 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Newer therapeutic agents including GLP-1 receptor agonists and GIP plus GLP dual agonists may decrease cardiovascular disease and diabetic kidney disease.

    “In addition, these newer therapeutic agents may decrease cardiovascular disease (CVD) 20 and diabetic kidney disease (DKD), 21 the major life-shortening complications of diabetes.[22][23][24]”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Nagel JM and Go¨ke B. Colorectal carcinoma screening in patients with type 2 diabetes mellitus. Z Gastroenterol 2006; 44(11): 1153-1165.

Cited by

Sorted by citations

Authors
Khalil, C. A., Roussel, R., Mohammedi, K., Danchin, N., & Marre, M.
Affiliations
  • Inserm (FR)
  • Hôpital Européen Georges-Pompidou (FR)
Corresponding author
Khalil, Charbel Abi
Venue
European Journal of Preventive Cardiology
Published
2011-04-28
Volume
19
Issue
3
Pages
374-381
ISSN
  • 2047-4873 (ISSN-L)
  • 2047-4881
OpenAlex
W2158850050
Cited by
98
References
52
Citations by year
2026: 3 · 2025: 3 · 2024: 5 · 2023: 7 · 2022: 9 · 2021: 5 · 2020: 9 · 2019: 2 · 2018: 9 · 2017: 12 · 2016: 7 · 2015: 9 · 2014: 11 · 2013: 5 · 2012: 2
FWCI
4.72
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Preventive Cardiology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
  • Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
Keywords
diabetes mortality, type 1 diabetes, type 2 diabetes, cause-specific mortality, mortality trends, cardiovascular complications, chronic complications, primary and secondary prevention, obesity epidemic, sedentary lifestyle, life expectancy
MeSH terms
Adolescent, Adult, Aged, Cardiovascular Diseases, Child, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Nephropathies, Europe, Female, Humans, Male, Middle Aged, Mortality, Neoplasms, Obesity, United States, Prevalence, Diabetes Complications, Young Adult, Sedentary Behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review